Skip to main content
Top
Published in: Diabetologia 2/2019

01-02-2019 | Short Communication

Gestational diabetes in young women predicts future risk of serious liver disease

Authors: Ravi Retnakaran, Jin Luo, Baiju R. Shah

Published in: Diabetologia | Issue 2/2019

Login to get access

Abstract

Aims/hypothesis

In common with type 2 diabetes, gestational diabetes mellitus (GDM) is associated with a propensity for hepatic fat deposition. We hypothesised that GDM predicts future lifetime risk of serious liver-disease outcomes, such as cirrhosis, liver failure and need for transplantation.

Methods

From population-based administrative databases, we identified all women in Ontario, Canada, who had a pregnancy resulting in live birth between April 1994 and March 2002 (N = 698,078). This population was stratified into individuals with (n = 17,932) and without (n = 680,146) GDM, and both groups were further stratified according to subsequent development of type 2 diabetes in the years after delivery. The median follow-up for the development of serious liver disease (defined as hospitalisation for cirrhosis, liver failure or transplantation) was 14.0 years.

Results

Women with GDM had a higher risk of serious liver disease than those without GDM (n = 680,146; HR = 1.40, 95% CI 1.01, 1.94). Compared with women who did not have GDM and did not develop diabetes (n = 635,998), those with GDM who subsequently developed type 2 diabetes (n = 8567) had a higher risk of serious liver disease (adjusted HR = 1.56, 95% CI 1.02, 2.39), as did those without GDM who developed type 2 diabetes (n = 44,148; adjusted HR = 2.48, 95% CI 2.10, 2.93), but not those with GDM who did not develop type 2 diabetes (n = 9365; adjusted HR = 1.15, 95% CI 0.69, 1.91).

Conclusion/interpretation

GDM is associated with future risk of serious liver disease in young women, the development of which may be dependent upon progression to non-gestational diabetes.
Literature
2.
go back to reference Prikoszovich T, Winzer C, Schmid AI et al (2011) Body and liver fat mass rather than muscle mitochondrial function determine glucose metabolism in women with a history of gestational diabetes mellitus. Diabetes Care 34(2):430–436. https://doi.org/10.2337/dc10-1002 Prikoszovich T, Winzer C, Schmid AI et al (2011) Body and liver fat mass rather than muscle mitochondrial function determine glucose metabolism in women with a history of gestational diabetes mellitus. Diabetes Care 34(2):430–436. https://​doi.​org/​10.​2337/​dc10-1002
4.
go back to reference Foghsgaard S, Andreasen C, Vedtofte L et al (2017) Nonalcoholic fatty liver disease is prevalent in women with prior gestational diabetes mellitus and independently associated with insulin resistance and waist circumference. Diabetes Care 40(1):109–116. https://doi.org/10.2337/dc16-1017 Foghsgaard S, Andreasen C, Vedtofte L et al (2017) Nonalcoholic fatty liver disease is prevalent in women with prior gestational diabetes mellitus and independently associated with insulin resistance and waist circumference. Diabetes Care 40(1):109–116. https://​doi.​org/​10.​2337/​dc16-1017
8.
go back to reference Tiikkainen M, Tamminen M, Häkkinen A-M et al (2002) Liver-fat accumulation and insulin resistance in obese women with previous gestational diabetes. Obes Res 10:859–867CrossRef Tiikkainen M, Tamminen M, Häkkinen A-M et al (2002) Liver-fat accumulation and insulin resistance in obese women with previous gestational diabetes. Obes Res 10:859–867CrossRef
Metadata
Title
Gestational diabetes in young women predicts future risk of serious liver disease
Authors
Ravi Retnakaran
Jin Luo
Baiju R. Shah
Publication date
01-02-2019
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 2/2019
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-018-4775-z

Other articles of this Issue 2/2019

Diabetologia 2/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.